Comment on Moderna loses $5B in market value after new data on RSV vaccine

Moderna loses $5B in market value after new data on RSV vaccine

Months before Moderna Inc. plans to launch its new RSV vaccine later this year, new data shows it gets less effective than its competitors over time.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News